Business & Finance
Drug-delivery company announces approval of all proposals at stockholders meeting
Published in Biotech Business Week, February 13th, 2006
At the special meeting held recently, the Emisphere stockholders approved the exchange of the 7-year 11% senior secured loan issued by Emisphere to affiliated funds of MHR Fund Management, LLC, (MHR) for an 11% senior secured convertible note and the subsequent issuance of the shares of Emisphere common stock underlying the convertible note. MHR has the right, but not the obligation, to exchange the loan for the convertible note. MHR is Emisphere's largest shareholder, currently owning approximately 14% of the company's outstanding shares....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Business Trends
Drug-discovery companies turn to low-cost Asian countries for greater cost savings - Cancer Therapy
Cancer treatment system non-invasively focuses heat on drug-injected region - Diabetes Epidemiology
U.S. diabetes population increases 86% in last decade to 14.5 million, market study shows - Market Analysis
More angiogenesis inhibitors expected to reach market in next 5 years, according to report - Stents
Increasing popularity of minimally invasive surgery drives growth in coronary stents market - Acute Bronchitis
Pelargonium sidoides root extract shown to shorten duration of acute bronchitis - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
